Table 1.
Factors Considered in the Present Study.
| Sex (men/women) | G20210A prothrombin gene mutation (No/Yes) | Red blood cell (RBC) count, µL−1 | Fasting blood glucose, mg·dL−1 |
| Age, years | Factor VIII (IU·dL−1) | Hemoglobin (HB) (g·dL−1) | Creatinine (mg·dL−1) |
| Pulmonary embolism (No/Yes) | Protein C level (PC) (mg dL-1) | Hematocrit (HCT) (%) | C-reactive protein (mg·dL−1) |
| Side of inferior member (left/right) | Protein S level (PS) (mg dL-1) | Red blood cell distribution (RDW) (%) | Arterial hypertension (No/Yes) |
| Location of VTE in leg (distal/ proximal) | Antithrombin level (AT) (mg dL-1) | Platelet (PLT) (µL-1) | Diabetes mellitus (No/Yes) |
| Provoked or unprovoked | Antiphospholipid syndrome (No/Yes) | Mean platelet volume (MVP) (fL) | Dyslipidemia (No/Yes) |
| Anticoagulation time, months | Body mass index (BMI) | Total cholesterol (mg·dL−1) | Renal failure (No/Yes) |
| Anticoagulant use (No/Yes) | Smoking (No/Yes) | High-density lipoprotein (HDL) (mg·dL−1) | Cancer (No/Yes) |
| d-dimer, ng·mL−1 | Hormonal therapy (for women) (No/Yes) | Low-density lipoprotein (LDL) (mg·dL−1) | Residual venous thrombus on US Doppler (No/Yes) |
| FV Leiden (No/Yes) | White blood cell (WBC) count (µL−1) | Triglycerides (mg·dL−1) |
Abbreviations: FV, factor V; US, ultrasound; AT, Antithrombin; PS, Protein S.